Progesterone News and Research

RSS

Research uncovers biological differences between male, female breast cancers

Male breast cancer (Male BC) has important biological differences that distinguish it from female breast cancer, but to date these have been little studied and Male BC patients have been excluded from many clinical trials in breast cancer.

11 Mar 2016

Researchers reveal direct link between Wbp2 gene and progressive hearing loss

Researchers at King's College London and the Wellcome Trust Sanger Institute in the United Kingdom have for the first time demonstrated a direct link between the Wbp2 gene and progressive hearing loss. The scientists report that the loss of Wbp2 expression leads to progressive high-frequency hearing loss in mouse as well as in two clinical cases of children with deafness with no other obvious features.

8 Feb 2016

Nutrition and breast cancer; starving triple negative breast cancer cells to death: an interview with Associate Professor Jeff Holst

While there are a range of reports that different foods and food groups can increase or decrease your risk of cancer, these associations are very difficult to scientifically verify.

27 Jan 2016

Migraines heat up as women near menopause

Migraine headaches heat up as women approach menopause, according to a new study from researchers at the University of Cincinnati, Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research.

21 Jan 2016

Study findings may help explain why risk of stroke changes after menopause

Risk of stroke in women may come down to a compound the body produces from estrogen known as 2-methoxyestradiol (2-ME). Furthermore, the compound's therapeutic potential may extend beyond treating stroke in women to healing brain injuries in men, a new study in American Journal of Physiology—Endocrinology and Metabolism reports.

20 Jan 2016

Racial disparity in 'previable' preterm births linked to infant mortality problem

Black women are nearly four times more likely than white women to have a baby born between 16 and 22 weeks gestation, a time period in which the life of a baby outside the womb is not viable.

13 Jan 2016

Biocept introduces blood-based test for detection, monitoring of prostate cancer and breast cancer

Biocept, Inc., a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the launch of the CLIA-validated androgen receptor expression assay using a patient's blood for the detection and monitoring of late-stage prostate cancer and a certain form of breast cancer.

7 Jan 2016

TSRI-led study finds potential new therapeutic approach for hard-to-treat breast cancers

Findings from a new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) suggest a potent new therapeutic approach for a number of hard-to-treat breast cancers.

21 Dec 2015

Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or not they received adjuvant chemotherapy, according to data from the phase III DBCG77B clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.

11 Dec 2015

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

Researchers from Caris Life Sciences and Fox Chase Cancer Center – Temple Health announced the presentation of two studies revealing the potential for exploring new therapeutic options for triple-negative breast cancer (TNBC) at the 2015 San Antonio Breast Cancer Symposium.

7 Dec 2015

Phase II study hints at oestriol effect in multiple sclerosis

Oestriol, given in combination with glatiramer acetate, may reduce the risk of relapse in women with relapsing–remitting multiple sclerosis, suggest findings from a phase II trial.

3 Dec 2015

Progesterone supplements fail to improve birth rate among women with a history of miscarriage

A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.

26 Nov 2015

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy

A University of Colorado Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage.

19 Nov 2015

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

Juniper Pharmaceuticals, Inc., a women's health therapeutics company, today announced financial results for the three months ended September 30, 2015.

11 Nov 2015

City of Hope awarded NIH grant to study potential link between environmental factors and breast cancer

The National Institutes of Health has awarded City of Hope a five-year, $4.8 million grant to study the possible role of chemicals in the environment in the development of breast cancer during the menopausal transition in women.

6 Nov 2015

March of Dimes Premature Birth Report Card reveals racial, ethnic disparities within states

Portland, Oregon has the best preterm birth rate of the top 100 cities with the most births nationwide, while Shreveport, Louisiana has the worst, according to the 2015 March of Dimes Premature Birth Report Card, which for the first time graded cities and counties around the nation and revealed persistent racial, ethnic and geographic disparities within states.

5 Nov 2015

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

A large international study shows that breastfeeding is associated with a lower risk of developing an aggressive form of breast cancer called hormone-receptor negative. This new combined evidence shows the risk was reduced by up to 20% in women who breastfed.

29 Oct 2015

Progesterone News and Research

Research uncovers biological differences between male, female breast cancers

Researchers reveal direct link between Wbp2 gene and progressive hearing loss

Nutrition and breast cancer; starving triple negative breast cancer cells to death: an interview with Associate Professor Jeff Holst

Migraines heat up as women near menopause

Study findings may help explain why risk of stroke changes after menopause

Racial disparity in 'previable' preterm births linked to infant mortality problem

Biocept introduces blood-based test for detection, monitoring of prostate cancer and breast cancer

TSRI-led study finds potential new therapeutic approach for hard-to-treat breast cancers

Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast cancer

Researchers reveal potential for exploring new treatment options for triple-negative breast cancer

Phase II study hints at oestriol effect in multiple sclerosis

Progesterone supplements fail to improve birth rate among women with a history of miscarriage

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy

Juniper Pharmaceuticals’ third quarter product revenues increase 22% to $7.2 million

City of Hope awarded NIH grant to study potential link between environmental factors and breast cancer

March of Dimes Premature Birth Report Card reveals racial, ethnic disparities within states

Breastfeeding associated with lower risk of developing hormone-receptor negative breast cancer

Research provides novel insight into potential new therapeutic targets for triple-negative breast cancer

Minority women with subtypes of breast cancer less likely to receive recommended treatment regimens

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News